Investors - Hikma Pharmaceuticals PLC

Share price analysis
Chairman's review
Financial Reports
Financial results
Presentations
RNS news
Events calendar
Analysts
Shareholder services
Corporate Governance
2009 financial calendar

This section of our website contains essential information on Hikma’s financial performance. View and download our results and reports, use our share price tools to monitor your investment, and keep up-to-date with the latest news and events.

17-Mar-2009

» Preliminary results announcement for the year ended 31 December 2008

LONDON, 17 March 2009 - Hikma Pharmaceuticals PLC (”Hikma”) (LSE:HIK) (DIFX:HIK), the fast-growing multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of generic and in-licensed pharmaceutical products, across the Middle East and North Africa, the US and Europe, today reports its preliminary results for the year ended 31 December 2008.

Download full preliminary results announcement

Skip Links

17-Mar-2009

463.75p (-3.64%)

© Copyright 2009 Hikma Pharmaceuticals PLC

Skip Links

17-Mar-2009

463.75p (-3.64%)

Susan Ringdal

2007 Annual Report

© Copyright 2009 Hikma Pharmaceuticals PLC